Sabby Management’s Redhill Biopharma RDHL Stock Holding History

Sabby Management’s Portfolio RDHL Stock Details RDHL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Hold	0	–	-$117K	–	197
2021 Q2	–	Hold	0	–	–	–	142

Other funds holding RDHL

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

CPA

Capital Performance Advisors Walnut Creek, California $1.5B AUM 21.4% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Danske Bank Copenhagen K, Denmark $41.5B AUM 29.19% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Sabby Management's RDHL Position: Q3 2024 in Review

Sabby Management sold out of Redhill Biopharma (RDHL) in Q3 2024, closing a stake of 53,648 shares — an estimated $497K sold.

Sabby Management first reported a position in RDHL in Q1 2015 and held it in 15 quarters. The position peaked at $4.62M in Q1 2021. 11 funds tracked by Wall St. Rank hold RDHL as of Q3 2024.

Sabby Management reported no remaining Redhill Biopharma position as of Q3 2024 after selling out during the quarter.
Sabby Management sold 53,648 Redhill Biopharma shares in Q3 2024, an estimated $497K.
Sabby Management first reported a position in Redhill Biopharma in Q1 2015 and held it in 15 quarters.
Sabby Management's Redhill Biopharma position peaked at $4.62M in Q1 2021.
11 funds tracked by Wall St. Rank held Redhill Biopharma as of Q3 2024.

Based on Sabby Management's 13F filing for Q3 2024, filed 14 Nov 2024.